Inventor · disambiguated record
Eran Elinav
Also filed as: ELINAV ERAN
12 granted patents·27 pending applications·49 citations·filing 2001–2025
89Inventor score
Files withYEDA RES & DEV25ENZO THERAPEUTICS INC5ILAN YARON2ELINAV ERAN1ENZO THERAPEUTICS INC C/O ENZO BIOCHEM INC1
Top patents by PatentIndex Score
39 records- 0189US10361003B2Method and apparatus for predicting response to foodYEDA RES & DEV·Filed 2015·Granted Jul 23, 2019·10 cites·46 claims
- 0289US8969291B2Methods for decreasing leptin levels or activity for treating inflammationILAN YARON·Filed 2010·Granted Mar 3, 2015·10 cites·10 claims
- 0386US10723797B2Methods for treating psoriasisENZO THERAPEUTICS INC·Filed 2019·Granted Jul 28, 2020·1 cites·4 claims
- 0484US9421257B2Methods for modulating Th1/Th2 cell balance by increasing leptin activityENZO THERAPEUTICS INC·Filed 2015·Granted Aug 23, 2016·3 cites·14 claims
- 0582US7863240B2Methods and uses of leptin in hepatocellular carcinomaENZO THERAPEUTICS INC·Filed 2004·Granted Jan 4, 2011·12 cites·4 claims
- 0681US12046371B2Method and apparatus for predicting response to foodYEDA RES & DEV·Filed 2023·Granted Jul 23, 2024·0 cites·20 claims
- 0774US8969292B2High affinity leptins and leptin antagonistsGERTLER ARIEH·Filed 2011·Granted Mar 3, 2015·8 cites·15 claims
- 0874US8043619B2Methods and uses of leptin in immune modulationILAN YARON·Filed 2004·Granted Oct 25, 2011·4 cites·1 claims
- 0972US2020331997A1Methods for treating psoriasisENZO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1071US11610681B2Method and apparatus for predicting response to foodYEDA RES & DEV·Filed 2021·Granted Mar 21, 2023·0 cites·20 claims
- 1171US10923230B2Method and apparatus for predicting response to foodYEDA RES & DEV·Filed 2019·Granted Feb 16, 2021·1 cites·48 claims
- 1271US2022184148A1Microbiome response to agentsYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 1368US12161679B2Microbiome-based diagnosis, prediction and treatment of relapsing obesityYEDA RES & DEV·Filed 2021·Granted Dec 10, 2024·0 cites·7 claims
- 1467US2019142875A1Microbiome-based diagnosis, prediction and treatment of relapsing obesityYEDA RES & DEV·Filed 2017·Application pending·0 cites
- 1565US11326147B2Redirected, genetically-engineered T regulatory cells and their use in suppression of autoimmune and inflammatory diseaseYEDA RES & DEV·Filed 2019·Granted May 10, 2022·0 cites·17 claims
- 1665US2019022152A1Microbiome response to agentsYEDA RES & DEV·Filed 2018·Application pending·0 cites
- 1765US2024094224A1Anti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated diseaseYEDA RES & DEV·Filed 2023·Application pending·0 cites
- 1864US2019382827A1Use of microbial metabolites for treating diseasesYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 1962US2018037648A1Methods for treating melanomaENZO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2059US2022184154A1Treatment of bacterial vaginosisYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 2158US2016319015A1Leptin in immune modulationENZO THERAPEUTICS INC C/O ENZO BIOCHEM INC·Filed 2016·Application pending·0 cites
- 2257US2022362329A1Treating acute liver disease with tlr-mik inihibitorsYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 2357US2023330051A1Method for modulating weightYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 2456US2020206283A1Bacterial populations for promoting healthYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 2556US2010135974A1Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory diseaseYEDA RES & DEV·Filed 2008·Application pending·0 cites
- 2655US2025213630A1Treatment of bacterial vaginosisYEDA RES & DEV·Filed 2025·Application pending·0 cites
- 2754US2016263166A1Microbiome response to agentsYEDA RES & DEV·Filed 2015·Application pending·0 cites
- 2852US2021353611A1Methods of treating amyotrophic lateral sclerosisYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 2952US2018140648A1Bacterial populations for promoting healthYEDA RES & DEV·Filed 2016·Application pending·0 cites
- 3052US2018148770A1Use of microbial metabolites for treating diseasesYEDA RES & DEV·Filed 2016·Application pending·0 cites
- 3147US2021269860A1Person-specific assessment of probiotics responsivenessYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 3245US2019343782A1Methods of treating liver toxicity and disordersYEDA RES & DEV·Filed 2017·Application pending·0 cites
- 3345US2020368322A1Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunctionYEDA RES & DEV·Filed 2020·Application pending·0 cites
- 3441US2005069546A1Educated NKT cells and their uses in the treatment of immune-related disordersFiled 2003·Application pending·0 cites
- 3541US2022031776A1Bacteriophage for modulating inflammatory bowel diseaseUNIV KEIO·Filed 2018·Application pending·0 cites
- 3641US2014377278A1Compositions and Methods for Assessing and Treating Inflammatory Diseases and DisordersELINAV ERAN·Filed 2012·Application pending·0 cites
- 3740US2016367661A1NLRP6 Inflammasome Intestinal Epithelium Mucus SecretionUNIV YALE·Filed 2015·Application pending·0 cites
- 3836US2019102512A1Method of analyzing microbiomeYEDA RES & DEV·Filed 2015·Application pending·0 cites
- 3934US2004087485A1Educated nkt cells and their uses in the treatment of immune-related disordersFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →